PT-141 (10mg), also known as Bremelanotide, is a synthetic peptide studied for its potential role in modulating sexual arousal pathways via the central nervous system. Unlike vascular-based compounds, PT-141 acts on melanocortin receptors in the brain and may support libido and sexual responsiveness in both males and females. This guide outlines a subcutaneous administration approach optimized for the 10 mg vial format.
Concise summary of the subcutaneous regimen.
Suggested approach for the 10 mg vial format.
PT-141 (Bremelanotide) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH). It works primarily by activating melanocortin receptors, especially MC3R and MC4R, located in the central nervous system.
Unlike PDE5 inhibitors that act on blood vessels, PT-141 influences neural pathways involved in sexual desire and arousal. This central mechanism may help initiate or enhance libido independently of vascular function. Research indicates effects on hypothalamic signaling pathways that regulate sexual motivation and response.
Observations based on clinical studies and approved medical use.
Potential Benefits:
Possible Side Effects: